Category: Autoimmune disease treatment

While initially developed for cancer treatment, rituximab has demonstrated varied levels of efficacy across numerous autoimmune diseases. The overall response rate (complete and partial) can be high, with one registry study showing an 86.7% response across various conditions, but success rates of **rituximab infusion for autoimmune disease** depend heavily on the specific disorder.

As a Janus kinase (JAK) inhibitor, Jakura 5mg Tablet (Tofacitinib) works by modulating the immune system to treat conditions like rheumatoid arthritis and ulcerative colitis. However, this action also carries a risk of various side effects, ranging from common infections to more serious cardiovascular events, making it crucial for patients to understand what are the side effects of Jakura 5mg Tablet.